Beneficial Effects of VEGF Secreted from Stromal Cells in Supporting Endothelial Cell Functions: Therapeutic Implications for Critical Limb Ischemia
Critical limb ischemia (CLI) is the end stage of peripheral vascular disease (PVD). One third of CLI patients progresses to leg amputation with high associated morbidity and mortality. In no-option patients with end-stage critical limb ischemia, bone marrow cell transplantation has shown promising r...
Main Authors: | Gilda Cobellis Ph.D., Ciro Maione, Chiara Botti, Antonietta Coppola, Andrea Silvestroni, Stefano Lillo, Vincenzo Schiavone, Anna Maria Molinari, Vincenzo Sica |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2010-11-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368910X509068 |
Similar Items
-
Autologous bone marrow cell therapy for peripheral arterial disease
by: Botti C, et al.
Published: (2012-09-01) -
Author Correction: Pro-inflammatory cytokines activate hypoxia-inducible factor 3α via epigenetic changes in mesenchymal stromal/stem cells
by: Francesca Cuomo, et al.
Published: (2020-04-01) -
Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia
by: Julie R Beegle, et al.
Published: (2016-01-01) -
Stromal vascular fraction cells for the treatment of critical limb ischemia: a pilot study
by: Adas Darinskas, et al.
Published: (2017-06-01) -
The role of indoleamine 2,3 dioxygenase in beneficial effects of stem cells in hind limb ischemia reperfusion injury.
by: Mohamad Masoumy, et al.
Published: (2014-01-01)